Lymphoma Panel

Brief about this service

Used for suspected lymphoid malignancies where lineage confirmation and subtype clarity are clinically important.

IHC panel workflow for lymphoma lineage and subtype refinement. Each case is processed under quality-controlled oncology diagnostics workflows for clinically meaningful output.

When this test is commonly used

• Cases where multi-marker interpretation improves diagnostic confidence.
• Differential diagnoses requiring lineage, subtype, or origin clarification.
• Oncology pathways needing marker-correlated, clinician-ready reporting.

Sample and reporting guidance

Provide representative tissue sections or blocks with relevant histology context so marker interpretation can be correlated accurately with morphology.

Reports are structured for doctor readability with concise interpretation notes and pathway-oriented communication.